Literature DB >> 31388807

Use of indocyanine green (ICG) augmented near-infrared fluorescence imaging in robotic radical resection of gallbladder adenocarcinomas.

Ali Ahmad1.   

Abstract

BACKGROUND: Gallbladder cancer remains a rare cancer with a poor prognosis. National guidelines recommend radical resection in the absence of metastatic disease. This often requires extensive dissection around the extrahepatic bile ducts. We report our experience of real-time near-infrared fluorescence imaging using indocyanine green during robotic radical resection of gallbladder adenocarcinomas.
METHODS: Ten patients with gallbladder adenocarcinoma underwent robotic radical resection entailing central hepatectomy (segments IV-B and V) with regional lymphadenectomy. Real-time NIRF imaging was performed using the da Vinci® Firefly system after intravenous administration of ICG 30 to 60 min preoperatively. Primary objective was to determine safety of this technique.
RESULTS: Procedure was successfully completed in all patients. Seven patients (70%) had incidentally discovered gallbladder cancer after laparoscopic cholecystectomy and five patients had preoperatively known positive margins. Mean operative time was 173 min. Mean intraoperative blood loss was 88 mL (30-200 mL). Median number of lymph nodes retrieved was 5 (2-8). High ligation of cystic duct was performed close to the common bile duct (CBD) junction with the assist of NIRF and negative margins were achieved in all patients. No major complications (Grade III-IV) or mortality was seen at 30 days post-op.
CONCLUSIONS: Results from our limited experience demonstrate procedural safety and beneficial use of NIRF using ICG during robotic radical resection of gallbladder adenocarcinomas. It may assist in attainment of negative cystic duct margin and lymphatic clearance around the biliary tree especially in complex re-explorative biliary surgery.

Entities:  

Keywords:  Biliary; Cancer; Gallbladder; Hepatectomy; ICG; Robotic

Mesh:

Substances:

Year:  2019        PMID: 31388807     DOI: 10.1007/s00464-019-07053-w

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  1 in total

1.  Surgery for gallbladder cancer in the US: a need for greater lymph node clearance.

Authors:  Thuy B Tran; Nicholas N Nissen
Journal:  J Gastrointest Oncol       Date:  2015-10
  1 in total
  7 in total

Review 1.  The Evolution of Fluorescence-Guided Surgery.

Authors:  Stan Van Keulen; Marisa Hom; Haley White; Eben L Rosenthal; Fred M Baik
Journal:  Mol Imaging Biol       Date:  2022-09-19       Impact factor: 3.484

2.  Insulin-Like Growth Factor-1 Receptor Targeted Fluorescent Imaging for Gallbladder Cancer in Orthotopic Mouse Models.

Authors:  Jung Ha Choi; Jeong Youp Park
Journal:  Gut Liver       Date:  2021-09-01       Impact factor: 4.321

Review 3.  Robotic Surgery for Biliary Tract Cancer.

Authors:  Lyonell B Kone; Philip V Bystrom; Ajay V Maker
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639

4.  EGFR-targeted fluorescent imaging using the da Vinci® Firefly™ camera for gallbladder cancer.

Authors:  Jung Ha Choi; Chang Moo Kang; Jeong Youp Park
Journal:  World J Surg Oncol       Date:  2022-06-15       Impact factor: 3.253

5.  A narrative review of fluorescence imaging in robotic-assisted surgery.

Authors:  Yu-Jin Lee; Nynke S van den Berg; Ryan K Orosco; Eben L Rosenthal; Jonathan M Sorger
Journal:  Laparosc Surg       Date:  2021-07-25

Review 6.  Preoperative Assessment and Perioperative Management of Resectable Gallbladder Cancer in the Era of Precision Medicine and Novel Technologies: State of the Art and Future Perspectives.

Authors:  Gianluca Cassese; Ho-Seong Han; Yoo-Seok Yoon; Jun Suh Lee; Jai Young Cho; Hae-Won Lee; Boram Lee; Roberto Ivan Troisi
Journal:  Diagnostics (Basel)       Date:  2022-07-05

7.  Laparoscopic surgery for oncologic extended resection of T1b and T2 incidental gallbladder carcinoma at a high-volume center: a single-center experience in China.

Authors:  Parbatraj Regmi; Hai-Jie Hu; Yin Chang-Hao; Fei Liu; Wen-Jie Ma; Cong-Dun Ran; Jun-Ke Wang; Aliza Paudyal; Nan-Sheng Cheng; Fu-Yu Li
Journal:  Surg Endosc       Date:  2020-11-10       Impact factor: 4.584

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.